Literature DB >> 32662253

Diabetic Retinopathy and Related Clinical Practice for People with Diabetes in Korea: A 10-Year Trend Analysis.

Yoo-Ri Chung1, Kyoung Hwa Ha2,3, Kihwang Lee1, Dae Jung Kim2,3.   

Abstract

We performed a retrospective cohort study including people diagnosed with diabetes from 2006 to 2015 according to the Korean National Health Insurance Service-National Sample Cohort database, to analyze the changes in the prevalence, screening rate, and treatment patterns for diabetic retinopathy (DR) over 10 years. The proportion of people who underwent fundus screening for DR steadily increased over the past decade. The prevalence of DR increased from 13.4% in 2006 to 15.9% in 2015, while that of proliferative DR steadily decreased from 1.29% in 2006 to 1.16% in 2015. The proportion of patients undergoing retinal photocoagulation constantly decreased. The prevalence of DR increased over the past decade, while its severity seemed to have improved, with a decreased rate of proliferative DR and retinal photocoagulation. A higher proportion of patients underwent ophthalmic screening using fundus examination, but still less than 30% of patients with diabetes underwent comprehensive examination in 2015.

Entities:  

Keywords:  Cohort studies; Diabetes mellitus; Diabetic retinopathy; Diagnostic screening programs

Year:  2020        PMID: 32662253     DOI: 10.4093/dmj.2020.0096

Source DB:  PubMed          Journal:  Diabetes Metab J        ISSN: 2233-6079            Impact factor:   5.376


  2 in total

1.  Visual Acuity Outcomes in Diseases Associated with Reduced Visual Acuity: An Analysis of the National Health Insurance Service Database in Korea.

Authors:  Sang-Yeob Kim; Byeong-Yeon Moon; Hyun-Gug Cho; Dong-Sik Yu
Journal:  Int J Environ Res Public Health       Date:  2022-07-17       Impact factor: 4.614

2.  Prevalence of Diabetic Retinopathy in Undiagnosed Diabetic Patients: A Nationwide Population-Based Study.

Authors:  Han Na Jang; Min Kyong Moon; Bo Kyung Koo
Journal:  Diabetes Metab J       Date:  2022-02-23       Impact factor: 5.893

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.